Beverly Moy Selected Research

N,N- dimethyl- N- hexadecyl- 1- octadecylammonium (DDAC)

12/2018	Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer.
12/2009	Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Beverly Moy Research Topics

Disease

68	Breast Neoplasms (Breast Cancer) 08/2022 - 11/2005
39	Neoplasms (Cancer) 01/2022 - 11/2005
8	Brain Neoplasms (Brain Tumor) 01/2021 - 11/2006
5	Circulating Neoplastic Cells 01/2022 - 04/2013
5	Disease Progression 12/2021 - 03/2016
4	Diarrhea 01/2020 - 07/2007
3	Fatigue 06/2022 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2020
3	Pathologic Complete Response 01/2020 - 10/2017
3	Exanthema (Rash) 04/2015 - 07/2007
2	Triple Negative Breast Neoplasms 12/2021 - 10/2021
2	Meningeal Carcinomatosis 08/2020 - 01/2020
2	Central Nervous System Diseases (CNS Diseases) 01/2020 - 03/2016
2	Neurologic Manifestations (Neurological Manifestations) 01/2019 - 03/2016
2	Pain (Aches) 12/2017 - 04/2015
2	Nausea 12/2017 - 03/2016
2	Vomiting 12/2017 - 03/2016
2	Cardiotoxicity 05/2011 - 07/2007
1	Premature Birth (Birth, Premature) 08/2022
1	Chorioamnionitis 08/2022
1	Rupture 08/2022
1	Death (Near-Death Experience) 01/2022
1	Microsatellite Instability 01/2022
1	Constipation 07/2021
1	COVID-19 10/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

18	Hormones (Hormone)IBA 01/2022 - 08/2006
16	Trastuzumab (Herceptin)FDA Link 08/2021 - 12/2009
12	human ERBB2 proteinIBA 01/2022 - 06/2010
12	Lapatinib (GW572016)FDA Link 11/2021 - 11/2006
11	Biomarkers (Surrogate Marker)IBA 06/2022 - 11/2006
11	neratinibIBA 11/2021 - 03/2016
8	ErbB Receptors (EGF Receptor)IBA 12/2021 - 10/2014
8	Paclitaxel (Taxol)FDA LinkGeneric 07/2019 - 11/2005
6	Estrogen ReceptorsIBA 10/2020 - 10/2014
5	Capecitabine (Xeloda)FDA Link 12/2021 - 01/2019
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 04/2014
3	pembrolizumabIBA 01/2022 - 01/2020
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2021 - 01/2017
3	Phenobarbital (Luminal)FDA Link 01/2019 - 10/2012
3	Aromatase InhibitorsIBA 01/2017 - 04/2014
2	Zoledronic Acid (Zometa)FDA Link 01/2022 - 06/2017
2	Fulvestrant (Faslodex)FDA Link 01/2022 - 11/2019
2	Diphosphonates (Bisphosphonates)IBA 01/2022 - 06/2017
2	Clodronic Acid (Clodronate)IBA 01/2022 - 06/2017
2	AlpelisibIBA 01/2022 - 11/2019
2	Circulating Tumor DNAIBA 01/2022 - 11/2020
2	AnthracyclinesIBA 12/2021 - 05/2011
2	taxaneIBA 12/2021 - 08/2021
2	sacituzumab govitecanIBA 10/2021 - 10/2021
2	AntigensIBA 10/2021 - 11/2020
2	Immunoconjugates (Immunoconjugate)IBA 10/2021 - 10/2021
2	ribociclibIBA 08/2021 - 01/2017
2	abemaciclibIBA 03/2021 - 01/2017
2	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2020
2	Cyclin-Dependent Kinase 4IBA 01/2020 - 01/2017
2	Loperamide (Imodium)FDA LinkGeneric 01/2020 - 03/2016
2	Pharmaceutical PreparationsIBA 01/2020 - 03/2016
2	palbociclibIBA 11/2019 - 01/2017
2	APTIBA 07/2019 - 06/2015
2	N,N- dimethyl- N- hexadecyl- 1- octadecylammonium (DDAC)IBA 12/2018 - 12/2009
2	Hemoglobins (Hemoglobin)IBA 02/2017 - 01/2013
2	exemestane (Aromasin)FDA Link 01/2017 - 04/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2016 - 11/2005
2	bosutinibIBA 04/2014 - 04/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2011 - 06/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2011 - 06/2010
1	Taxoids (Taxanes)IBA 08/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2022
1	Denosumab FDA Link 01/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	dostarlimabIBA 01/2022
1	hydroxide ionIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Ibandronic Acid (Boniva)FDA Link 01/2022
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	Monoclonal AntibodiesIBA 10/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2021
1	Surface Antigens (Surface Antigen)IBA 10/2021
1	Ado-Trastuzumab EmtansineIBA 08/2021
1	Carcinoembryonic AntigenIBA 11/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	olaparibIBA 01/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	Formaldehyde (Formol)FDA Link 11/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2019

Therapy/Procedure

39	Therapeutics 01/2022 - 08/2006
23	Drug Therapy (Chemotherapy) 08/2022 - 11/2005
9	Adjuvant Chemotherapy 08/2020 - 11/2005
4	Radiotherapy 01/2021 - 11/2013
4	Mastectomy (Mammectomy) 08/2020 - 01/2012
4	Neoadjuvant Therapy 01/2020 - 01/2013
1	Aftercare (After-Treatment) 08/2022
1	Terminal Care (Care, Terminal) 01/2022
1	Palliative Care (Palliative Therapy) 01/2022
1	Operative Surgical Procedures 10/2020
1	Segmental Mastectomy (Lumpectomy) 08/2020
1	Craniotomy 01/2020